ICRF-187 (ADR-529) cardioprotection against anthracycline-induced cardiotoxicity: clinical and preclinical studies
Related Experiment Videos
Cancer Treatment and Research
|January 1, 1991
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
A phase 2 feasibility study of nab-paclitaxel and carboplatin in epithelial carcinoma of the uterus.
Gynecologic oncology·2024
BRCA mutations and outcome in epithelial ovarian cancer (EOC): experience in ethnically diverse groups.
Annals of oncology : official journal of the European Society for Medical Oncology·2013
Proteasome inhibition with bortezomib (PS-341): a phase I study with pharmacodynamic end points using a day 1 and day 4 schedule in a 14-day cycle.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2005
Platinums: extending their therapeutic spectrum.
Journal of chemotherapy (Florence, Italy)·2005
Sequential single agents as first-line chemotherapy for ovarian cancer: a strategy derived from the results of GOG-132.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2003
Complement activation following first exposure to pegylated liposomal doxorubicin (Doxil): possible role in hypersensitivity reactions.
Annals of oncology : official journal of the European Society for Medical Oncology·2003
Clinical Trials and Translational Advances in Metabolic Targeting.
Cancer treatment and research·2026
Tools and Technologies for Studying Cancer Metabolism.
Cancer treatment and research·2026
Cancer and Immune Cells: A Metabolic Battle in the Tumor Microenvironment.
Cancer treatment and research·2026
Biomarkers of Cancer Metabolism and Therapeutic Response.
Cancer treatment and research·2026
Targeting Metabolism in Cancer Therapy: Inhibitors and Approaches.
Cancer treatment and research·2026
Metabolic Reprogramming in Cancer Stem Cells.
Cancer treatment and research·2026